A MULTICENTER, OPEN-LABEL, PHASE 3, RANDOMIZED TRIAL OF DUVELISIB VS INVESTIGATOR'S CHOICE (GEMCITABINE OR BENDAMUSTINE) IN RELAPSED/REFRACTORY NODAL T-CELL LYMPHOMA WITH T-FOLLICULAR HELPER PHENOTYPE

Introduction

This mock abstract represents content that will later be loaded from the S3 object named soho2026.7530a4d.Abstract.html.

Methods

The study summarizes conference submission metadata, authorship, affiliations, topic classification, presenter details, and linked poster media.

Conclusion

These placeholder sections preserve the detail-page structure while the production integration is connected to MySQL and S3.